Enhanced Glioblastoma Selectivity of Harmine via the Albumin Carrier.
Sign Up to like & getrecommendations! Published in 2022 at "Journal of biomedical nanotechnology"
DOI: 10.1166/jbn.2022.3321
Abstract: Glioblastoma, the most common tumor in the brain, has witnessed very little clinical progress over the last decades. Exploring and discovering new therapeutic strategies for glioblastoma has become a critical problem. Harmine (HM), belonging to… read more here.
Keywords: glioblastoma selectivity; selectivity harmine; enhanced glioblastoma; selectivity ... See more keywords